Global sgRNA (Single Guide RNA) Market Strategic Research Report

Scope of the Report

The global sgRNA (Single Guide RNA) market size is predicted to grow from US$ 607 million in 2025 to US$ 1,884 million in 2032; it is expected to grow at a CAGR of 17.6% from 2026 to 2032.

Single Guide RNA (sgRNA) is a synthetic RNA molecule used in CRISPR-Cas9 gene editing systems. It combines two natural RNA components—crRNA (CRISPR RNA) and tracrRNA (trans-activating CRISPR RNA)—into a single engineered strand.In 2025, global sgRNA production reached approximately 1.94 M units, with an average global market price of around US$ 320 per unit. Annual production capacity is 2.35 M units. Gross Profit Margin: 58%.The sgRNA industry chain is structured around three main layers: upstream raw material synthesis, midstream manufacturing, and downstream application markets. Upstream consists of RNA nucleotide chemicals, phosphoramidite reagents, and enzymatic IVT systems used to produce guide RNA. Midstream players such as IDT, Synthego, GenScript, and Thermo Fisher specialize in chemical synthesis, IVT production, purification, and modification of sgRNA. Downstream demand is driven by CRISPR-based research, drug discovery, gene therapy development, agricultural genome editing, and molecular diagnostics, where sgRNA functions as a core targeting component of gene editing systems.sgRNA is not just a consumable reagent but a foundational enabling component of the entire CRISPR ecosystem. Its value is shifting from basic research usage toward high-value applications such as cell therapy and in vivo gene editing, where demand for chemically modified and high-precision sgRNAs is increasing. Over time, the market is likely to evolve from a sequence-based pricing model to a performance-grade stratified system, where stability, efficiency, and clinical-grade quality become the main value drivers rather than simple synthesis cost.

Global key sgRNA (Single Guide RNA) players cover Integrated DNA Technologies, Thermo Fisher Scientific, Synthego Corporation, GenScript Biotech, Horizon Discovery Group, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global sgRNA (Single Guide RNA) market?

What factors are driving sgRNA (Single Guide RNA) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do sgRNA (Single Guide RNA) market opportunities vary by end market size?

How does sgRNA (Single Guide RNA) break out by Delivery State at Use, by Application?

This report presents a comprehensive overview of the global sgRNA (Single Guide RNA) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Delivery State at Use

• Direct RNA Products
• Expression-based sgRNA
• Pre-assembled RNP

Segment by Modification Status

• Unmodified sgRNA
• Chemically Modified sgRNA
• Others

Segment by Structural Format

• Single-guide RNA
• crRNA + tracrRNA Duplex

Segment by Application

• Biomedical Research
• Drug Discovery & Pharmaceutical R&D
• Agricultural & Plant Biotechnology
• Industrial Biotechnology & Synthetic Biology
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global sgRNA (Single Guide RNA) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Biomedical Research, Drug Discovery & Pharmaceutical R&D, Agricultural & Plant Biotechnology evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact